No Data
No Data
AstraZeneca Stock Up Almost 14% in 6 Months: Time to Buy?
AstraZeneca in AI Collaboration With Immunai to Inform Cancer Drug Trials
TAGRISSO (Osimertinib) Approved in the US for Patients With Unresectable, Stage III EGFR-mutated Lung Cancer
AstraZeneca: FDA Approves Tagrisso To Treat Unresectable Stage III Lung Cancer
Express News | FDA Approves Osimertinib For Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer After Chemoradiation Therapy; Recommended Dose Is 80mg Daily Until Disease Progression Or Unacceptable Toxicity
AstraZeneca PLC (AZN) Annual Deutsche Bank Leveraged Finance Conference (Transcript)
ひな☆彡 SOXL : You convinced me. I am happy to buy some later.
Growth Investor27 : Long ESPR $1.61 is very cheap.
Growth Investor27 : Long150,000 will hold for 5x upside for 2025 if not aquired.